Summary
Indirect immunofluorescence histochemistry and receptor autoradiography were used to study the localization of transmitter-/peptidecontaining neurons and peptide binding sites in the mediobasal hypothalamus in normal rats and in rats treated neonatally with repeated doses of the neurotoxin monosodium-glutamate (MSG). In the arcuate nucleus, the results showed a virtually complete loss of cell bodies containing immunoreactivity for growth hormone-releasing factor (GRF), galanin (GAL), dynorphin (DYN), enkephalin (ENK), corticotropin-like intermediate peptide (CLIP), neuropeptide Y (NPY), and neuropeptide K (NPK). Tyrosine hydroxylase(TH)-, glutamic acid decarboxylase(GAD)-, neurotensin(NT)- and somatostatin(SOM)-immunoreactive (IR) cells were, however, always detected in the ventrally dislocated, dorsomedial division of the arcuate nucleus. In the median eminence, marked decreases in numbers of GAD-, NT-, GAL-, GRF-, DYN-and ENK-IR fibers were observed. The numbers of TH-, SOM-and NPY-IR fibers were in contrast not or only affected to a very small extent, as revealed with the immunofluorescence technique. Biochemical analysis showed a tendency for MSG to reduce dopamine levels in the median eminence of female rats, whereas no effect was observed in male rats. Autoradiographic studies showed high to moderate NT binding sites, including strong binding over presumably dorsomedial dopamine cells. In MSG-treated rats, there was a marked reduction in GAL binding in the ventromedial nucleus. The findings implicate that most neurons in the ventrolateral and ventromedial arcuate nucleus are sensitive to the toxic effects of MSG, whereas a subpopulation of cells in the dorsomedial division of the arcuate nucleus, including dopamine neurons, are not susceptible to MSG-neurotoxicity. The results indicate, moreover that the very dense TH-IR fiber network in the median eminence predominantly arises from the dorsomedial TH-IR arcuate cells, whereas the GAD-, NT-, GAL-, GRF-and DYN-IR fibers in the median eminence to a large extent arise from the ventrolateral arcuate nucleus. Some ENK-and NPK-positive cells in the arcuate nucleus seem to project to the lateral palisade zone of the median eminence, but most of the ENK-IR fibers in the median eminence, located in the medial palisade zone, seem to primarily originate from an area(s) located outside the arcuate nucleus, presumably the paraventricular nucleus. The NPY-positive fibers in the median eminence contain to a large extent immunoreactive dopamine β-hydroxylase (DBH), and do not arise from the ventromedial arcuate nucleus. SOM-IR cells in the dorsal periventricular arcuate nucleus do not send major projections to the median eminence. The present findings thus show that MSG treatment represents a valuable tool to clarify the organization of chemically identified neuron populations in the arcuate nucleus-median eminence complex and provide further information for understanding the neuroendocrine effects of neonatal MSG treatment.
Similar content being viewed by others
References
Agid Y, Javoy F, Glowinski J (1973) Hyperactivity of remaining dopaminergic neurons after partial destruction of the nigrostriatal dopaminergic system in the rat. Nature 245:150–151
Ajika K, Hökfelt T (1975) Projections to the median eminence and the arcuate nucleus with special reference to monoamine systems: effects of lesions. Cell Tiss Res 158:15–35
Antoni FA, Kanyicska B, Mezey E, Makara GB (1982) Neona-tal treatment with monosodium-L-glutamate: differential effects in growth hormone and prolactin release induced by morphine. Neuroendocrinology 35:231–235
Badger TM, Millard WJ, Martin JB, Rosenblum PM, Levenson SE (1982) Hypothalamic-pituitary function in adult rats treated neonatally with monosodium glutamate. Endocrinology 111:2031–2038
Bai FL, Yamano M, Shiotani Y, Emson P, Smith AD, Powell JF, Tohyama M (1985) An arcuato-paraventricular and dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. Brain Res 331:172–175
Bakke JL, Lawrence N, Bennet J, Robinson S, Bowers CY (1978) Late endocrine effects of administering monosodium glutamate to neonatal rats. Neuroendocrinology 26:220–228
Barry J, Hoffman GE, Wray S (1985) LHRH-containing systems. In: Björklund A, Hökfelt T (eds) Handbook of chemical neuroanatomy, Vol. 4. GABA and neuropeptides in the CNS, Part 1. Elsevier, Amsterdam, pp 166–215
Björklund A, Lindvall O (1984) Dopamine-containing systems in the CNS. In: Björklund A, Hökfelt T (eds) Handbook of chemical neuroanatomy, Vol. 2. Classical transmitters in the CNS, Part 1. Elsevier, Amsterdam, pp 55–122
Bloch B, Ling N, Benoit R, Wehrenberg WB, Guillemin R (1984) Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence. Nature 307:272–273
Brownstein MJ, Arimura A, Fernandez-Durango R, Schally AV, Palkovits M, Kizer JS (1977) The effect of hypothalamic deafferentation on somatostatin-like immunoreactivity in rat brain. Endocrinology 100:246–249
Buchan AMJ, Sikora LKJ, Levy JG, McIntosh CHS, Dyck I, Brown JC (1985) An immunocytochemical investigation with monoclonal antibodies to somatostatin. Histochemistry 83:175–180
Carson KA, Nemeroff CB, Rone MS, Youngblood WW, Prange AJ, Hanker JS, Kizer JS (1977) Biochemical and histochemical evidence for the existence of a tuberoinfundibular cholinergic pathway in the rat. Brain Res 129:169–173
Ceccatelli S, Eriksson M, Hökfelt T (1989) Distribution and coexistence of CRF-, neurotensin-, enkephalin-, cholecystokinin-, galanin-and VIP/PHI-like peptides in the parvocellular part of the paraventricular nucleus. Neuroendocrinology 49:309–323
Chronwall BM, Chase TN, O'Donohue TL (1984) Coexistence of neuropeptide Y and somatostatin in rat and human cortical neurons and rat hypothalamic neurons. Neurosci Lett 52:213–217
Clemens JA, Roush ME, Fuller RW, Shaar CJ (1978) Changes in luteinizing hormone and prolactin control mechanisms produced by glutamate lesions of the arcuate nucleus. Endocrinology 103:1304–1312
Coons AH (1958) Fluorescent antibody methods. In: Danielli JF (ed) General cytochemical methods. Academic Press, New York, pp 399–422
Critchlow V, Rice RW, Abe K, Vale WW (1978) Somatostatin content of the median eminence in female rats with lesioninduced disruption of the inhibitory control of growth hormone secretion. Endocrinology 103:817–825
Crowley WR, Terry LC (1980) Biochemical mapping of somatostatinergic systems in rat brain: effects of periventricular and medial basal amygdaloid lesions on somatostatin-like immunoreactivity in discrete brain nuclei. Brain Res 200:283–291
Dada MO, Blake CA (1985) Monosodium-L-glutamate administration: effects on gonadotrophin secretion, gonadotrophs and mammotrophs in prepubertal rats. J Endocrinol 104:185–192
Dahlström A, Fuxe K (1964) Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in cell bodies of brain stem neurons. Acta Physiol Scand 62: Suppl 232:1–55
Daikoku S, Kawano H, Noguchi M, Nakanishi J, Tokuzen M, Chihara K, Nagatsu I (1986) GRF neurons in the rat hypothalamus. Brain Res 399:250–261
Davis TME, Burrin JM, Bloom SR (1987) Growth hormone (GH) release in response to GH-releasing hormone in man is 3-fold enhanced by galanin. J Clin Endocrinol Metab 65:1248–1252
Dawson R Jr., Valdes JJ, Annau Z (1985) Tuberohypophyseal and tuberoinfundibular dopamine systems exhibit differential sensitivity to neonatal monosodium glutamate treatment. Pharmacology 31:17–23
De Quidt ME, Emson PC (1985) Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system. II. Immunohistochemical analysis. Neuroscience 18:545–618
Elde RP, Hökfelt T (1978) Distribution of hypothalamic hormones and other peptides in the brain. In: Ganong WF, Martini L (eds) Frontiers in neuroendocrinology, Vol 5. Raven Press, New York, pp 1–33
Emson PC, Goedert M, Mantyh PW (1985) Neurotensin-containing neurons. In: Björklund A, Hökfelt T (eds) Handbook of chemical neuroanatomy, Vol. 4. GABA and neuropeptides in the CNS, Part 1. Elsevier, Amsterdam, pp 355–405
Enjalbert A, Arancibia S, Priam M, Bluet-Pajot MT, Kordon C (1982) Neurotensin stimulation of prolactin secretion in vitro. Neuroendocrinology 34:95–98
Everitt BJ, Hökfelt T, Wu J-Y, Goldstein M (1984a) Coexistence of tyrosine hydroxylase-like and gamma-aminobutyric acid-like immunoreactivities in neurons of the arcuate nucleus. Neuroendocrinology 39:189–191
Everitt BJ, Hökfelt T, Terenius E, Tatemoto K, Mutt V, Goldstein M (1984b) Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience 11:443–462
Everitt BJ, Meister B, Hökfelt T, Melander T, Terenius E, Rökaeus Å, Theodorsson-Norheim E, Dockray G, Edwardson J, Cuello C, Elde R, Goldstein M, Hemmings H, Ouimet C, Walaas I, Greengard P, Vale W, Weber E, Wu J-Y, Chang K-J (1986) The hypothalamic arcuate nucleus-median eminence complex: immunohistochemistry of transmitters, peptides and DARPP-32 with special reference to coexistence in dopamine neurons. Brain Res Rev 11:97–155
Felice EJ, Felice JD, Kissinger PT (1978) Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography. J Neurochem 31:1461–1465
Frey P (1983) Cholecystokinin octapeptide (CCK 26–33), nonsulfated octapeptide and tetrapeptide (CCK 30–33) in rat brain: analysis by high pressure liquid chromatography (HPLC) and radioimmunoassay (RIA). Neurochem Int 5:811–815
Fuxe K (1964) Cellular localization of monoamines in the median eminence and infundibular stem of some mammals. Z Zellforsch 61:719–724
Fuxe K, Hökfelt T (1966) Further evidence for the existence of tubero-infundibular dopamine neurons. Acta Physiol Scand 66:245–246
Fuxe K, Hökfelt T (1971) Histochemical fluorescence detection of changes in central monoamine neurones provoked by drugs acting on the CNS. Triangle, Sandoz Journal of Medical Science 10:73–84
Fuxe K, Hökfelt T, Löfström A, Johansson O, Agnati E, Everitt B, Goldstein M, Jeffcoate S, White N, Eneroth P, Gustafsson J-Å (1976) On the role of neurotransmitters and hypothalamic hormones and their interactions in hypothalamic and extrahypothalamic control of pituitary function and sexual behavior. In: Naftolin F, Ryan KJ, Davies J (eds) Subcellular mechanisms in reproductive neuroendocrinology. Elsevier, Amsterdam, pp 193–246
Fuxe K, Andersson K, Agnati E, Ferland E, Hökfelt T, Eneroth P, Gustafsson J-Å (1980) Hypothalamic monoamine pathways and their possible role in disturbances of the secretion of hormones from the anterior pituitary gland. In: Faglia G, Giovanelli MA, MacLeod RM (eds) Pituitary microadenomas. Academic Press, New York, pp 15–35
Fuxe K, Agnati EF, Andersson K, Eneroth P, Härfstrand A, Goldstein M, Zoli M (1984) Studies on neurotensin-catecholamine interactions in the hypothalamus and in the forebrain of the male rat. Neurochem Int 6:737–750
Fuxe K, Agnati E, Kalia M, Goldstein M, Andersson K, Härfstrand A (1985) Dopaminergic systems in the brain and pituitary. In: Flückiger E, Müller EE, Thorner MO (eds) The dopaminergic system. Springer, Berlin, pp 11–25
Goldstein M, Anagnoste B, Freedman ES, Roffman M, Ebstein RP, Park DH, Fuxe K, Hökfelt T (1973) Characterization, localization and regulation of catecholamine-synthesizing enzymes. In: Usdin E, Snyder S (eds) Frontiers in catecholamine research. Pergamon Press, New York, pp 69–78
Gabriel SM, MacGarvey UM, Koenig JI, Swartz KJ, Martin JB, Beal MF (1988) Characterization of galanin-like immunoreactivity in the rat brain: effects of neonatal glutamate treatment. Neurosci Lett 87:114–126
Greeley GH, Nicholson GF, Nemeroff CB, Youngblood WW, Kizer JS (1978) Direct evidence that the arcuate nucleusmedian eminence tuberoinfundibular system is not of primary importance in the feedback regulation of luteinizing hormone and follicle-stimulating hormone secretion in the castrated rat. Endocrinology 103:170–175
Greeley GH, Nicholson GF, Kizer JS (1980) A delayed EH/ FSH rise after gonadectomy and a delayed serum TSH rise after thyroidectomy in monosodium-E-glutamate(MSG)-treated rats. Brain Res 195:111–122
Hökfelt T, Fahrenkrug J, Tatemoto K, Mutt V, Werner S, Hulling A-E, Terenius E, Chang KJ (1983) The PHI (PHI-27)/ corticotropin-releasing factor/enkephalin immunoreactive hypothalamic neuron: possible morphological basis for integrated control of prolactin, corticotropin, and growth hormone secretion. Proc Natl Acad Sci USA 80:985–989
Hökfelt T, Everitt BJ, Theodorsson-Norheim E, Goldstein M (1984) Occurrence of neurotensin like immunoreactivity in subpopulations of hypothalamic, mesencephalic and medullary catecholamine neurons. J Comp Neurol 222:543–549
Hökfelt T, Meister B, Everitt B, Staines W, Melander T, Schalling M, Mutt V, Hulting A-E, Werner S, Bartfai T, Nordström Ö, Fahrenkrug J, Goldstein M (1987) Chemical neuroanatomy of the hypothalamo-pituitary axis: focus on multimessenger systems. In: McCann SM, Weiner RI (eds) Integrative neuroendocrinology: molecular cellular and clinical aspects. Karger, Basel, pp 1–34
Holzwarth-McBride MA, Hurst EM, Knigge KM (1976a) Monosodium glutamate induced lesions of the arcuate nucleus. I. Endocrine deficiency and ultrastructure of the median eminence. Anat Rec 186:185–196
Holzwarth-McBride MA, Sladek JR, Knigge KM (1976b) Monosodium glutamate induced lesions of the arcuate nucleus. II. Fluorescence histochemistry of catecholamines. Anat Rec 186:197–206
Ibata Y, Fukui K, Okamura H, Kawakami T, Tanaka M, Obata HL, Tsuto T, Terubayashi H, Yanaihara C, Yanaihara N (1983) Coexistence of dopamine and neurotensin in hypothalamic arcuate and periventricular neurons. Brain Res 269:177–179
Ibata Y, Kawakami F, Fukui K, Obata-Tsuto HL, Tanaka M, Kubo T, Okamura H, Moimoto N, Yanaihara C, Yanaihara N (1984) Light and electron microscopic immunocytochemistry of neurotensin-like immunoreactive neurons in the rat hypothalamus. Brain Res 302:221–230
Ishikawa K, Taniguchi Y, Kurosumi K, Suzuki M, Shinoda M (1987) Immunohistochemical identification of somatostatin-containing neurons projecting to the median eminence of the rat. Endocrinology 121:94–97
Jaeger CB, Ruggiero DA, Albert VR, Park DH, Joh TH, Reis DJ (1984) Aromatic L-amino acid decarboxylase in the rat brain: immunohistochemical localization in monoamine and non-monoamine neurons of the brain stem. Neuroscience 11:691–713
Jennes L, Stumpf WE, Kalivas PW (1982) Neurotensin: topographical distribution in rat brain by immunohistochemistry. J Comp Neurol 210:211–224
Jennes L, Stumpf WE, Bissette G, Nemeroff CB (1984) Monosodium glutamate lesions in rat hypothalamus studied by immunohistochemistry for gonadotropin releasing hormone, neurotensin, tyrosine hydroxylase, and glutamic acid decarboxylase and by autoradiography for (3H)estradiol. Brain Res 308:245–253
Johansson O, Hökfelt T, Elde RP (1984) Immunohistochemical distribution of somatostatin-like immunoreactivity in the central nervous system of the adult rat. Neuroscience 13:265–339
Johnson DG, De C Nogueira Araujo GM (1981) A simple method of reducing the fading of immunofluorescence during microscopy. J Immunol Methods 43:349
Kahn D, Abrams G, Zimmerman EA, Carraway R, Leeman SE (1981) Neurotensin neurons in the rat hypothalamus: an immunocytochemical study. Endocrinology 107:47–53
Kawano H, Daikoku S (1988) Somatostatin-containing neuron systems in the rat hypothalamus: retrograde tracing and immunohistochemical studies. J Comp Neurol 271:293–299
Kawano H, Daikoku S, Saito S (1982) Immunohistochemical studies of intrahypothalamic somatostatin-containing neurons in rat. Brain Res 242:227–232
Khachaturian H, Lewis ME, Schäfer MK-H, Watson SJ (1985) Anatomy of CNS opioid system. Trends Neurosci 8:111–119
Kiss A, Palkovits M, Antoni FA, Eskay RL, Skirboll LR (1987) Neurotensin in the rat median eminence: possible sources of neurotensin-like fibers and varicosities in the external layer. Brain Res 416:129–135
Koshiyama H, Kato Y, Shimatsu A, Katakami H, Yanaihara N, Imura H (1987) Central galanin stimulates pituitary prolactin secretion in rats: possible involvement of hypothalamic vasoactive intestinal polypeptide. Neurosci Lett 75:49–54
Krieger DA, Liotta A, Nicholsen G, Kizer J (1979) Brain ACTH and endorphin reduced in rats with monosodium glutamate induced arcuate nuclear lesions. Nature 278:562–563
Kyrkouli SE, Stanley BG, Leibovitz SF (1986) Galanin: stimulation of feeding induced by medial hypothalamic stimulation of this novel peptide. Eur J Pharmacol 122:159–160
Lechan RM, Alpert LC, Jackson IMD (1976) Synthesis of luteinising hormone releasing factor and thyrotropin-releasing factor in glutamate-lesioned mice. Nature 264:463465
Lechan RM, Nestler JL, Jacobson S (1982) The tuberoinfundibular system of the rat as demonstrated by immunohistochemical localization of retrogradely transported wheat germ agglutinin (WGA) from the median eminence. Brain Res 245:1–15
Liposits Z, Merchenthaler I, Paull WK, Flerkó B (1988) Synaptic communication between somatostatinergic axons and growth hormone-releasing factor (GRF) synthesizing neurons in the arcuate nucleus of the rat. Histochemistry 89:247–252
Ljungdahl Å, Hökfelt T, Nilsson G (1978) Distribution of substance P-like immunoreactivity in the central nervous system of the rat. I. Cell bodies and nerve terminals. Neuroscience 3:861–943
Lundberg JM, Terenius L, Hökfelt T, Tatemoto K (1984) Comparative immunocytochemical and biochemical analysis of pancreatic polypeptide-like peptides with special reference to presence of neuropeptide Y in central and peripheral neurons. J Neurosci 4:2376–2386
MacLeod RM, Lehmeyer JE (1974) Studies on the mechanism of dopamine-mediated inhibition of prolactin secretion. Endocrinology 94:1077–1085
Maeda K, Frohman LA (1978) Dissociation of systemic and central effects of neurotensin on the secretion of growth hormone, prolactin, and thyrotropin. Endocrinology 103:1903–1908
Makara GB, Kakucska I, Lenoir V, Kerdelhue B, Palkovits M (1986) A substance P-containing hypothalamic neuronal system projects to the median eminence. Brain Res 374:399–401
Markey KA, Kondo S, Shenkman I, Goldstein M (1980) Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line. Mol Pharmacol 17:79–85
McGinty JF, Bloom F (1983) Double immunostaining reveals distinctions among opioid peptidergic neurons in the medial basal hypothalamus. Brain Res 278:145–153
Meister B, Hökfelt T (1988) Peptide-and transmitter-containing neurons in the mediobasal hypothalamus and their relation to GABAergic systems: possible roles in control of prolactin and growth hormone secretion. Synapse 2:585–605
Meister B, Hökfelt T, Steinbusch HWM, Skagerberg G, Lindvall O, Geffard M, Joh TH, Cuello AC, Goldstein M (1988a) Do tyrosine hydroxylase-immunoreactive neurons in the ventrolateral arcuate nucleus produce dopamine or only L-DOPA J Chem Neuroanat 1:59–64
Meister B, Hökfelt T, Geffard M, Oertel W (1988b) Glutamic acid decarboxylase-and γ-aminobutyric acid-like immunoreactivities in corticotropin-releasing factor-containing parvocellular neurons of the hypothalamic paraventricular nucleus. Neuroendocrinology 48:516–526
Meister B, Hökfelt T, Tsuruo Y, Hemmings H, Ouimet C, Greengard P, Goldstein M (1988c) DARPP-32, a dopamine-and cyclic AMP-regulated phosphoprotein, in tanycytes of the mediobasal hypothalamus: distribution and relation to dopamine and luteinizing hormone-releasing hormone neurons and other glial elements. Neuroscience 27:607–622
Melander T, Hökfelt T, Rökaeus Å (1986a) Distribution of galaninlike immunoreactivity in the rat central nervous system. J Comp Neurol 248:475–517
Melander T, Hökfelt T, Rökaeus Å, Cuello AC, Oertel WH, Verhofstad A, Goldstein M (1986b) Coexistence of galaninlike immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J Neurosci 6: 3640–3654
Melander T, Fuxe K, Härfstrand A, Eneroth P, Hökfelt T (1987) Effects of intraventricular injections of galanin on neuroendocrine functions in the male rat: possible involvement of hypothalamic catecholamine nerve terminal systems. Acta Physiol Scand 131:25–32
Melander T, Köhler C, Nilsson S, Hökfelt T, Brodin E, Theodorsson E, Bartfai T (1988) Autoradiographic quantitation and anatomical mapping of 125I-galanin binding sites in the rat central nervous system. J Chem Neuroanat 1:213–233
Millard WJ, Martin JB Jr., Audet J, Sagar SM, Martin JB (1982) Evidence that reduced growth hormone secretion observed in monosodium glutamatetreated rats is the result of a deficiency in growth hormone-releasing factor. Endocrinology 110:540–550
Murakami Y, Kato Y, Koshiyama H, Inoue T, Yanaihara N, Imura H (1987) Galanin stimulates growth hormone (GH) secretion via GH-releasing factor (GRF) in conscious rats. Eur J Pharmacol 136:415–418
Nagasawa M, Yanai R, Kikuyama S (1974) Irreversible inhibition of pituitary prolactin and growth hormone secretion and of mammary gland development in mice by monosodium glutamate administered neonatally. Acta Endocrinol (Copenh) 75:249–259
Nemeroff CB, Konkol RJ, Bissette G, Youngblood W, Martin JB, Brazeau P, Rone MS, Prange AJ Jr, Breese GR, Kizer JS (1977a) Analysis of the disruption in hypothalamic-pituitary regulation in rats treated neonatally with monosodium L-glutamate (MSG): evidence for the involvement of tuberoinfundibular cholinergic and dopaminergic systems in neuroendocrine regulation. Endocrinology 101:613–622
Nemeroff CB, Grant LD, Bissette G, Ervin GN, Harreil LE, Prange AJ (1977b) Growth, endocrinological and behavioural deficits after monosodium L-glutamate in the neonatal rat: possible involvement of arcuate dopamine neuron damage. Psychoneuroendocrinology 2:179–196
Nemeroff CB, Lipton MA, Kizer JS (1978) Models of neuroendocrine regulation: use of monosodium glutamate as an investigational tool. Dev Neurosci 1:102–109
Nordström Ö, Melander T, Hökfelt T, Bartfai T, Goldstein M (1987) Evidence for an inhibitory effect of the peptide galanin on dopamine release from the rat median eminence. Neurosci Lett 73:21–26
Norstedt G, Mode A, Hökfelt T, Eneroth P, Elde R, Ferland L, Labrie F, Gustafsson J-Å (1983) Possible role of somatostatin in the regulation of the sexually differentiated steroid metabolism and prolactin receptor in rat liver. Endocrinology 112:1076–1090
Oertel WH, Schmechel DE, Tappaz ML, Kopin IJ (1981) Production of a specific antiserum to rat brain glutamic acid decarboxylase by injection of an antigen-antibody complex. Neuroscience 6:2689–2700
Okamura H, Kitahama K, Nagatsu I, Geffard M (1988a) Comparative topography of dopamine- and tyrosine hydroxylase-immunoreactive neurons in the rat arcuate nucleus. Neurosci Lett 95:347–353
Okamura H, Kitahama K, Raynaud B, Nagatsu I, Borri-Volttatorni C, Weber M (1988b) Aromatic L-amino acid decarboxylase(AADC)-immunoreactive cells in the tuberal region of the rat hypothalamus. Biomed Res 9:261–267
Okamura H, Kitahama K, Mons N, Ibata Y, Jouvet M, Geffard M (1988c) L-DOPA-immunoreactive neurons in the rat tuberal region. Neurosci Lett 95:42–46
Olney JW (1969) Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164:719–721
Olney JW (1971) Glutamate-induced neuronal necrosis in the infant mouse hypothalamus. J Neuropathol Exp Neurol 30:75–90
Olney JW, Ho O (1970) Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature 227:609–611
Olney JW, Schainker B, Rhee V (1975) Chemical lesioning of the hypothalamus as a means of studying neuroendocrine function. In: Sachar E (ed) Hormones, behavior and psychopathology. Raven Press, New York, pp 153–158
Ottlecz A, Samson WK, McCann SM (1985) Galanin: evidence for a hypothalamic site of action to release growth hormone. Peptides 7:51–53
Ouimet CC, Miller PE, Hemmings HC Jr, Walaas SI, Greengard P (1984) DARPP-32, a dopamine-and cyclic adenosine-3′: 5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J Neurosci 4:11–124
Palkovits M (1986) Neuropeptides in the median eminence. Neurochem Int 9:131–139
Palkovits M, Rökaeus Å, Antoni FA, Kiss A (1987) Galanin in the hypothalamo-hypophyseal system. Neuroendocrinology 46:417–423
Patel YC, Hoyte K, Martin JB (1979) Effect of anterior hypothalamic lesions on neurohypophyseal and peripheral tissue concentrations of somatostatin in the rat. Endocrinology 105:712–715
Perez VJ, Olney JW (1972) Accumulation of glutamic acid in the arcuate nucleus of the hypothalamus of the infant mouse following subcutaneous administration of monosodium glutamate. J Neurochem 19:1777–1782
Pilcher WH, Joseph S (1986) Differential sensitivity of hypothalamic and medullary opiocortin and tyrosine hydroxylase neurons to the neurotoxic effects of monosodium glutamate. Peptides 7:783–789
Pizzi WJ, Barnhart JE, Fanslow DJ (1977) Monosodium glutamate administration to the newborn reduces reproductive ability in female and male mice. Science 196:452–454
Platt JL, Michael AF (1983) Retardation of fading and enhancement of intensity of immunofluorescence by p-phenylenediamine. J Histochem Cytochem 31:840–842
Rao ZR, Yamano M, Wanaka A, Tatehata T, Shiosaka S, Tohyama M (1987) Distribution of cholinergic neurons and fibers in the hypothalamus of the rat using choline acetyltransferase as a marker. Neuroscience 20:923–934
Redding TW, Schally AV, Arimura A, Wakabayashi I (1971) Effect of monosodium glutamate on some endocrine functions. Neuroendocrinology 8:245–255
Robbins TW (1986) Hunger. In: Lightman SL, Everitt BJ (eds) Neuroendocrinology. Blackwell, London, pp 252–303
Rökaeus Å, Melander T, Hökfelt T, Lundberg JM, Tatemoto K, Carlquist M, Mutt V (1984) A galanin-like peptide in the central nervous system and intestine of the rat. Neurosci Lett 47:161–166
Romagnano MA, Chafel TL, Pilcher WH, Joseph S (1982a) The distribution of enkephalin in the mediobasal hypothalamus of the mouse brain: effects of neonatal administration of MSG. Brain Res 236:497–504
Romagnano MA, Pilcher WH, Bennett-Clarke C, Chafel TL, Joseph SA (1982b) Distribution of somatostatin in the mouse brain: effects of neonatal MSG treatment. Brain Res 234:387–398
Rose PA, Weick RF (1987) Evidence for reorganization of neuroendocrine centres regulating pulsatile LH secretion in rats receiving neonatal monosodium-L-glutamate. J Endocrinology 113:261–269
Sawchenko PE, Swanson LW, Vale WW (1984) Co-expression of corticotropin-releasing factor- and vasopressin-immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc Natl Acad Sci USA 81:1883–1887
Sawchenko PE, Swanson LW, Rivier J, Vale WW (1985a) The distribution of growth hormone-releasing factor (GRF)-immunoreactivity in the central nervous system of the rat: an immunohistochemical study using antisera directed against rat hypothalamic GRF. J Comp Neurol 237:100–115
Sawchenko PE, Swanson L, Grzanna R, Howe PRC, Bloom SR, Polak JM (1985b) Colocalization of neuropeptide Y immunoreactivity in brain stem catecholaminergic neurons that project to the paraventricular nucleus of hypothalamus. J Comp Neurol 241:138–153
Schultzberg M, Lundberg JM, Hökfelt T, Terenius L, Brandt J, Elde RP, Goldstein M (1978) Enkephalin-like immunore-activity in gland cells and nerve terminals of the adrenal medulla. Neuroscience 3:1169–1186
Seal A, Liu E, Buchan A, Brown J (1988) Immunoneutralization of somatostatin and neurotensin: effect on gastric acid secretion. Am J Physiol 255:G40-G45
Shimada S, Inagaki S, Kubota Y, Kito S, Shiotani Y, Tohyama M (1987) Coexistence of substance P- and enkephalin-like peptides in single neurons of the rat hypothalamus. Brain Res 425:256–262
Simpson EL, Gold RM, Standish LJ, Pellett PL (1977) Axonsparing brain lesioning technique: the use of monosodiumL-glutamate and other amino acids. Science 198:515–517
Skofitsch G, Jacobowitz DM (1985) Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides 6:509–546
Stoeckel ME, Tappaz M, Hindelang C, Seweryn C, Porte A (1985) Opposite effects of monosodium glutamate on the dopaminergic and GABAergic innervation of the median eminence and the intermediate lobe in the mouse. Neurosci Lett 56:249–255
Tago H, McGeer PL, Bruce G, Hersch LB (1987) Distribution of choline acetyltransferase-containing neurons of the hypothalamus. Brain Res 415:49–62
Tatemoto K, Lundberg JM, Jörnvall H, Mutt V (1985) Neuropeptide K: isolation, structure and biological activities of a novel brain tachykinin. Biochem Biophys Res Commun 128:947–953
Tempel DL, Leibowitz KJ, Leibowitz SF (1988) Effects of PVN galanin on macronutrient selection. Peptides 9:309–314
Terry LC, Epelbaum J, Martin JB (1981) Monosodium glutamate: acute and chronic effects on rhythmic growth hormone and prolactin secretion, and somatostatin in the undisturbed male rat. Brain Res 217:129–142
Tramu G, Pillez A, Leonardelli J (1978) An efficient method of antibody elution for the successive or simultaneous location of two antigens by immunocytochemistry. J Histochem Cytochem 26:322–324
Tsuruo Y, Kawano H, Hishiyama T, Hisano S, Daikoku S (1983) Substance P-like immunoreactive neurons in the tuberoinfundibular area of rat hypothalamus. Brain Res 289:1–9
Valentino KL, Tatemoto K, Hunter J, Barchas JD (1986) Distribution of neuropeptide K-immunoreactivity in the rat central nervous system. Peptides 7:1043–1059
Vijayan E, McCann SM (1979) Effects of substance P and neurotensin on gonadotropin and prolactin release. Endocrinology 105:64–68
Vincent S, Hökfelt T, Christensson I, Terenius L (1982) Dynorphin-immunoreactive neurons in the central nervous system of the rat. Neurosci Lett 33:185–190
Visser TJ, Klootwijk W, Doctor R, Henneman G (1977) A different approach to the radioimmunoassay of thyrotropinreleasing hormone. In: Radioimmunoassay and related procedure in medicine. National Atomic Agency, Vienna, pp 469–477
Walaas I, Fonnum F (1978) The effect of parenteral glutamate treatment on the localization of neurotransmitters in the mediobasal hypothalamus. Brain Res 153:549–562
Watson SJ, Akil H, Fischli W, Goldstein A, Zimmerman E, Nilaver G, van Wimersma Greidanus TB (1982) Dynorphin and vasopressin: common localization in magnocellular neurons. Science 216:85–87
Wessendorf MW, Elde RP (1985) Characterization of an immunofluorescence technique for the demonstration of coexisting neurotransmitters within nerve fibers and terminals. J Histochem Cytochem 33:984–994
Wiegand SJ, Price JL (1980) Cells of origin of the afferent fibers to the median eminence in the rat. J Comp Neurol 192:1–19
Young III WS, Kuhar MJ (1979) A new method for receptor autoradiography: 3H-opioid receptor labeling in mounted tissue sections. Brain Res 179:255–270
Zamboni L, De Martino S (1967) Buffered acid formaldehyde: a new rapid fixative for electron microscopy. J Cell Biol 148A:35
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meister, B., Ceccatelli, S., Hökfelt, T. et al. Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate (MSG) lesions. Exp Brain Res 76, 343–368 (1989). https://doi.org/10.1007/BF00247894
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00247894